FibroGen to Sell China Unit to AstraZeneca for $160 Million

In This Article:

FibroGen (FGEN) said Thursday it has agreed to sell its China subsidiary to AstraZeneca (AZN) for ab

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.